Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bisacodyl suppository versus standard care for early recovery after cesarean section
PACTR202512709170316Not yet recruiting
- Sponsor
- Haliru Kadiri
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bisacodyl in postoperative ileus (POI) (2 arms), sponsored by Haliru Kadiri. Primary endpoint: Time to first bowel movement. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
bisacodyl
03
Conditions
postoperative ileus (POI)
Beyond the preview
Go deeper on PACTR202512709170316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202512709170316.